These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30620188)

  • 21. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.
    Longhena F; Spano P; Bellucci A
    Handb Exp Pharmacol; 2018; 245():85-110. PubMed ID: 28965171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(4-styrenesulfonate) as an inhibitor of Aβ40 amyloid fibril formation.
    Ojha B; Liu H; Dutta S; Rao PP; Wojcikiewicz EP; Du D
    J Phys Chem B; 2013 Nov; 117(45):13975-84. PubMed ID: 24015976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA).
    Herva ME; Zibaee S; Fraser G; Barker RA; Goedert M; Spillantini MG
    J Biol Chem; 2014 Apr; 289(17):11897-11905. PubMed ID: 24584936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact between the β1 and β2 Segments of α-Synuclein that Inhibits Amyloid Formation.
    Shaykhalishahi H; Gauhar A; Wördehoff MM; Grüning CS; Klein AN; Bannach O; Stoldt M; Willbold D; Härd T; Hoyer W
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8837-40. PubMed ID: 26119103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and mechanistic insights into amyloid-β and α-synuclein fibril formation and polyphenol inhibitor efficacy in phospholipid bilayers.
    Sanders HM; Jovcevski B; Marty MT; Pukala TL
    FEBS J; 2022 Jan; 289(1):215-230. PubMed ID: 34268903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN; Kumar R; Panigrahi R; Navalkar A; Ghosh D; Sahay S; Mondal M; Kumar A; Maji SK
    ACS Chem Neurosci; 2017 Dec; 8(12):2722-2733. PubMed ID: 28872299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of amyloid-β peptides from solution by sequestration within fibril-seeded hydrogels.
    Yau WM; Tycko R
    Protein Sci; 2018 Jul; 27(7):1218-1230. PubMed ID: 29417648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in vivo analysis.
    Kelley AR; Colley ME; Perry G; Bach SBH
    J Mass Spectrom; 2018 Feb; 53(2):162-171. PubMed ID: 29111606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission electron microscopy characterization of fluorescently labelled amyloid β 1-40 and α-synuclein aggregates.
    Anderson VL; Webb WW
    BMC Biotechnol; 2011 Dec; 11():125. PubMed ID: 22182687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Interaction of Protein-Pigment C-Phycocyanin with Bovine Serum Albumin in a Gomphosis Structure Inhibiting Amyloid Formation.
    Luo YC; Jing P
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions.
    Cieplak AS
    PLoS One; 2017; 12(9):e0180905. PubMed ID: 28922400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies.
    Henríquez G; Gomez A; Guerrero E; Narayan M
    ACS Chem Neurosci; 2020 Oct; 11(19):2915-2934. PubMed ID: 32822152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation.
    Liu Y; Pukala TL; Musgrave IF; Williams DM; Dehle FC; Carver JA
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6336-40. PubMed ID: 24157371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation on the Molecular Interactions Stabilizing the Structure of α-synuclein Fibril: An In silico Study.
    Sanjeev A; Mattaparthi VSK
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):209-218. PubMed ID: 28460628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta.
    Wagner WJ; Gross ML
    Mass Spectrom Rev; 2024; 43(4):782-825. PubMed ID: 36224716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptides as modulators of α-synuclein aggregation.
    Ruzza P; Gazziero M; Marchi MD; Massalongo G; Marchiani A; Autiero I; Tessari I; Bubacco L; Calderan A
    Protein Pept Lett; 2015; 22(4):354-61. PubMed ID: 25666040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
    Hsiao G; Chou PH; Shen MY; Chou DS; Lin CH; Sheu JR
    J Agric Food Chem; 2005 Oct; 53(20):7734-40. PubMed ID: 16190625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,2,4-trihydroxynaphthalene-2-O-β-D-glucopyranoside delays amyloid-β
    Dhouafli Z; Leri M; Bucciantini M; Stefani M; Gadhoumi H; Mahjoub B; Ben Jannet H; Guillard J; Ksouri R; Saidani Tounsi M; Soto C; Hayouni EA
    Biofactors; 2018 May; 44(3):272-280. PubMed ID: 29582494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.